Launch of patent database with pharma buy-in

25 September 2018

The World Intellectual Property Organization (WIPO) and a global trade body representing research-based pharma have launched an online tool to help procurement agencies better understand the global patent status of medicines.

On the Patent Information Initiative for Medicines (Pat-INFORMED), intellectual property holders provide information about patents covering approved therapies through a free, open access database.

WIPO is hosting the database and providing resources to ensure its continued development, while the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is working closely with the 20 leading research-based biopharmaceutical companies that have backed the initiative to bring a consistent and coordinated approach.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK